News | Stents Carotid | December 13, 2022

InspireMD Announces “12 Days of Carotid Stenting” Video Series Featuring Fireside Chats with Top Multidisciplinary Vascular Specialists

Series to feature leading experts discussing the current and future trends in the carotid treatment market

Series to feature leading experts discussing the current and future trends in the carotid treatment market

December 13, 2022 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced a video series, “12 Days of Carotid Stenting,” which will feature leading multidisciplinary vascular specialists discussing the current and future trends in the carotid treatment market. The series will be available for viewing beginning on Monday, November 28, 2022. 

Marvin Slosman, chief executive officer of InspireMD, stated, “This truly unique video series featuring some of the most renowned thought leaders in the field of vascular interventions, and we are grateful that they have taken the time to participate in this important initiative. Topics that will be discussed include current market trends, momentum toward endovascular standard of care, technology differentiation and clinical results, delivery system topics including TCAR and TFEM approaches, and the overall progression of the landscape toward further conversion of surgical interventions to stenting. Importantly, the series will also highlight the distinct advantages of CGuard™ versus competing stent platforms for carotid revascularization and stroke prevention thus supporting our belief that CGuard can soon become the global standard of care for the treatment of carotid artery disease.” 

The video series will feature perspectives from the following thought leaders in the field of vascular interventions: 

  • Chris Metzger, MD, System Chair of Clinical Research at Ballard Health and a practicing interventional cardiologist who serves as Director of Holston Valley Medical Center’s diagnostic catheterization and interventional labs 
  • Sean Lyden, MD, Professor and Chairman of the Department of Vascular Surgery at Cleveland Clinic 
  • Tommaso Castrucci, MD, Vascular, Endovascular and Emergency Vascular Surgery Unit, "S. Eugenio" Hospital, Rome, Italy 
  • Adnan Siddiqui, MD, PhD, FACS, FAHA, FAANS, Director, Canon Stroke & Vascular Research Center at SUNY University at Buffalo, Professor of Neurosurgery & Radiology at University at Buffalo Neurosurgery (UBNS) 
  • Kenneth Rosenfield, MD, Section Head, Vascular Medicine and Intervention at Massachusetts General Hospital and Chairman, ST-Elevation Myocardial Infarction (STEMI) & Acute Myocardial Infarction Quality Improvement Committee 

The full Fireside Chat can be viewed at: www.inspiremd.com/en/fireside-chat-series/, along with brief sections on the company’s LinkedIn page. 


Related Content

News | Heart Failure

May 25, 2023 — New data presented from an investigator-sponsored European trial found managing indicated1 heart failure ...

Home May 26, 2023
Home
News | Heart Failure

May 23, 2023 — Sacubitril/valsartan leads to greater reduction in plasma NT-proBNP levels compared to valsartan alone ...

Home May 23, 2023
Home
News | Heart Failure

May 23, 2023 — The diagnosis of heart failure is usually missed, denying patients treatments that could improve ...

Home May 23, 2023
Home
News | Heart Failure

May 23, 2023 — The first investigator-initiated study of remote pulmonary artery pressure monitoring has found that it ...

Home May 23, 2023
Home
News | Heart Failure

April 25, 2023 — Windtree Therapeutics, Inc., a biotechnology company focused on advancing late-stage interventions for ...

Home April 25, 2023
Home
News | Heart Failure

April 21, 2023 — A recent study using mice has revealed a way to turn back the clock after heart attack. The researchers ...

Home April 21, 2023
Home
News | Heart Failure

April 21, 2023 — Black adults with heart failure (HF) are more likely to die than white adults with the same condition ...

Home April 21, 2023
Home
News | Heart Failure

April 20, 2023 — The American College of Cardiology (ACC) has recognized seven Hackensack Meridian Health medical ...

Home April 20, 2023
Home
News | Heart Failure

April 14, 2023 — Deaths from cardiovascular disease are elevated on polluted days and for two days afterwards, according ...

Home April 14, 2023
Home
News | Heart Failure

April 11, 2023 — Daxor Corporation, a global leader in blood volume measurement technology, announced five new hospitals ...

Home April 11, 2023
Home
Subscribe Now